Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Health Network, Toronto
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Intermediate-risk prostate cancer patients (T1/T2N0M0 with either GS \< 7 and PSA between 10-20 ng/ml or GS 7 and PSA less than 20 ng/ml).
Planned for radical RT to the prostate with IMRT planning (79Gy/39fractions or 60 Gy/20 fractions).
No contraindications to diagnostic CT scanning.
Prostate volumes will be less than 80 cc to control the planning dose volume histogram (DVH) as much as possible in terms of rectal and bladder volumes.
No known DNA repair disorders (e.g. family history of AT, BRCA1/2 or Li Fraumeni syndrome) or contraindications to radical pelvic RT.
You may not be if
Inability to provide informed consent.
Patient having contraindications to diagnostic CT scan.
Patients who have unobtainable data regarding previous therapy and their clinical outcome.
Patients should not have any diagnostic X-rays or CAT scans 2 weeks prior to their enrollment into the study.
